Pierre‐François Pénélaud

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)

Véronique Crutel, Pierre‐François Pénélaud, Cristina Albarrán Severo et al. · Journal of Autism and Developmental Disorders · 2020 · 33 citations · Full text

Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase <scp>III</scp> studies

Joaquín Fuentes, Mara Parellada, Christina Georgoula et al. · Autism Research · 2023 · 32 citations · Full text

Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries

Celso Arango, Jan K. Buitelaar, Jörg M. Fegert et al. · The Lancet Psychiatry · 2021 · 31 citations

Psychiatry, Children's Mental Health, Medicine +15

Economic analysis of the use of recombinant human granulocyte colony stimulating factor in autologous bone marrow transplantation

E. Souêtre, Wenqi Qing, Pierre‐François Pénélaud · European Journal of Cancer · 1996 · 20 citations

Regenerative Medicine, Cell Therapy, Transplantation +10

Absence of Psychostimulant Effects of a Supratherapeutic Dose of Tianeptine

Katy Bernard, Pierre‐François Pénélaud, Elisabeth Mocaër et al. · Journal of Clinical Psychopharmacology · 2011 · 16 citations